AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

CannaPharmaRX, Inc.

$0 -$0.01 (-77.27%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0.01
Market Cap
1.36M
AVG Volume
149.34K
Trailing/Forward PE
-0.12/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0200K400K600K800K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q2276.22K
26 Q1627.46K
25 Q4138.63K
25 Q3656.61K
25 Q2231.61K
25 Q1335.32K
24 Q4482.13K
24 Q3312.16K
24 Q20
24 Q125.84K
Net Income (USD)
-15M-10M-5M05M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-1.91M
26 Q1-382.02K
25 Q4-7.55M
25 Q3-1.48M
25 Q2-1.41M
25 Q1-691K
24 Q4-3.74M
24 Q3188.42K
24 Q25.36M
24 Q1-11.72M
Operating Income (USD)
-2M-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-378.83K
26 Q1-682.34K
25 Q4-893.55K
25 Q3-935.65K
25 Q2-840.98K
25 Q1-668K
24 Q4-1.52M
24 Q3-498K
24 Q2-347K
24 Q1-790K
EBITDA (USD)
-15M-10M-5M05M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-378.83K
26 Q1405.14K
25 Q4-6.94M
25 Q3-961.22K
25 Q2-734.82K
25 Q1-49.55K
24 Q4-1.49M
24 Q3821.38K
24 Q26.16M
24 Q1-11.12M
Cash Flows (USD)
-1M-500K0500K1M1.5M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2243.66K
26 Q1-243.66K
25 Q41.06M
25 Q3-802.7K
25 Q2-446.46K
25 Q1-601.38K
24 Q4-179.89K
24 Q3-540.9K
24 Q2-427.62K
24 Q1-548.83K
EPS (USD)
-0.04-0.0200.0224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0
26 Q1-0
25 Q4-0.01
25 Q3-0
25 Q2-0
25 Q1-0
24 Q4-0.01
24 Q30
24 Q20.01
24 Q1-0.03
Expenses (USD)
-1M01M2MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2176.51K
26 Q1141.67K
25 Q41.44M
25 Q3-541.27K
25 Q2-282.29K
25 Q1-443.34K
24 Q4156.28K
24 Q3141.79K
24 Q2282.33K
24 Q1304.46K
Cash & Debt (USD)
05M10M15M20MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2555
26 Q1633
25 Q41.8K
25 Q3927
25 Q216.98K
25 Q11.21K
24 Q42.16K
24 Q37K
24 Q29.14K
24 Q112.09K
Debt ratios
-15-10-50524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Debt ratios by quarter
PeriodDebt ratios
26 Q2-2.62
26 Q1-2.55
25 Q4-2.38
25 Q3-7.73
25 Q2-12.27
25 Q13.08
24 Q4-2.5
24 Q33.75
24 Q24.76
24 Q1-2.83
Margins
-2000%-1500%-1000%-500%0%500%23 Q424 Q124 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Margins by quarter
PeriodMargins
26 Q2-50.12%
26 Q1-65.26%
25 Q4-375.89%
25 Q3-67.01%
25 Q2-268.22%
25 Q1-150.01%
24 Q4-350.73%
24 Q3-114.04%
24 Q1-1780.25%
23 Q450%
Return on Capital
-50%-25%0%25%50%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Return on Capital by quarter
PeriodReturn on Capital
26 Q26.19%
26 Q11.26%
25 Q425.04%
25 Q36.56%
25 Q26.26%
25 Q13.37%
24 Q418.88%
24 Q3-1.14%
24 Q2-32.17%
24 Q149.79%
Shares Outstanding
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2682.48M
26 Q1669.79M
25 Q4662.5M
25 Q3662.5M
25 Q2662.5M
25 Q1662.5M
24 Q4625.28M
24 Q3662.5M
24 Q2657.98M
24 Q1350.52M
Book Value Per Share (USD)
-0.08-0.06-0.04-0.02024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q2-0.05
26 Q1-0.05
25 Q4-0.05
25 Q3-0.03
25 Q2-0.03
25 Q1-0.03
24 Q4-0.03
24 Q3-0.03
24 Q2-0.03
24 Q1-0.07
Total Assets (USD)
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CPMD Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q26.89M
26 Q16.58M
25 Q47.02M
25 Q311.62M
25 Q211.47M
25 Q111.23M
24 Q410.84M
24 Q311.68M
24 Q211.71M
24 Q111.37M
Employee Count
01020302014201520182019202020212022202320242025
CPMD Employee Count by quarter
PeriodEmployee Count
202526
202426
20233
20222
20214
20204
20194
20189
20158
20149
PE Ratio
051015med 3.36Jun 24Sep 24Nov 24Jan 25Mar 25Jun 25Aug 25
CPMD PE Ratio by quarter
PeriodPE Ratio
Aug 251.3
Aug 251.9
Jul 251.9
Jul 251.78
Jul 252.07
Jul 252.31
Jun 252.31
Jun 251.9
Jun 252.37
Jun 252.61
May 252.01
May 252.9
May 251.84
Apr 252.21
Mar 251.92
Mar 251.92
Mar 252.64
Mar 252.64
Feb 251.92
Feb 253.36
Feb 253.36
Feb 253.46
Jan 253.46
Jan 253.55
Jan 254.03
Jan 252.45
Jan 253.79
Dec 243.6
Dec 243.75
Dec 243.84
Dec 243.84
Nov 243.75
Nov 244.23
Nov 244.8
Nov 249.86
Nov 2411.54
Oct 2410.28
Oct 2410.28
Oct 2410.39
Oct 248.61
Sep 2411.54
Sep 2410.49
Sep 248.4
Sep 2410.49
Aug 249.97
Aug 2410.65
Aug 2411.02
Jun 241.21
Jun 241.42
Jun 241.52
May 241.34
May 241.36
May 240.97
Free Cash Flow Yield
-150%-100%-50%0%50%med -60.46%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CPMD Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2618.55%
Sep 2615.46%
Aug 2615.46%
Aug 2619.53%
Aug 26-34.33%
Aug 26-32.61%
Jul 26-31.06%
Jul 26-31.06%
Jul 26-36.24%
Jul 26-28.36%
Jul 26-28.36%
Jun 26-27.18%
Jun 26-28.36%
Jun 26-93.18%
Jun 26-25.09%
May 26-26.09%
May 26-17.63%
May 26-39.98%
May 26-32.42%
May 26-34.27%
Apr 26-29.99%
Apr 26-30.75%
Apr 26-38.69%
Apr 26-27.89%
Mar 26-71.27%
Mar 26-76.62%
Mar 26-62.55%
Mar 26-62.55%
Feb 26-72.97%
Feb 26-85.13%
Feb 26-85.13%
Feb 26-87.57%
Jan 26-76.62%
Jan 26-76.62%
Jan 26-57.83%
Jan 26-47.15%
Jan 26-34.83%
Dec 25-51.08%
Dec 25-62.55%
Dec 25-76.62%
Dec 25-76.62%
Nov 25-76.62%
Nov 25-68.11%
Nov 25-68.11%
Nov 25-59.33%
Oct 25-53.39%
Oct 25-55.62%
Oct 25-55.62%
Oct 25-88.99%
Oct 25-88.99%
Sep 25-88.99%
Sep 25-88.99%
Sep 25-88.99%
Sep 25-83.43%
Aug 25-88.99%
Aug 25-88.99%
Aug 25-83.43%
Aug 25-120.05%
Aug 25-82.54%
Jul 25-82.54%
Jul 25-88.04%
Jul 25-75.46%
Jul 25-67.72%
Jun 25-67.72%
Jun 25-82.54%
Jun 25-66.03%
Jun 25-60.03%
May 25-77.68%
May 25-53.9%
May 25-85.2%
May 25-82.25%
May 25-61.69%
Apr 25-61.69%
Apr 25-61.69%
Apr 25-49.35%
Apr 25-92.65%
Mar 25-106.55%
Mar 25-106.55%
Mar 25-77.49%
Mar 25-77.49%
Feb 25-106.55%
Feb 25-60.88%
Feb 25-60.88%
Feb 25-59.19%
Jan 25-59.19%
Jan 25-57.59%
Jan 25-50.74%
Jan 25-83.57%
Jan 25-53.95%
Dec 24-56.83%
Dec 24-54.64%
Dec 24-53.27%
Dec 24-53.27%
Nov 24-54.64%
Nov 24-48.43%
Nov 24-42.62%
Nov 24-34.97%
Nov 24-29.88%
Oct 24-33.54%
Oct 24-33.54%
Price to Sales
0100200300med 1.9Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CPMD Price to Sales by quarter
PeriodPrice to Sales
Sep 260.8
Sep 260.96
Aug 260.96
Aug 260.76
Aug 260.77
Aug 260.81
Jul 260.85
Jul 260.85
Jul 260.73
Jul 260.93
Jul 260.93
Jun 260.97
Jun 260.93
Jun 260.28
Jun 261.05
May 261.01
May 261.5
May 261.46
May 261.8
May 261.7
Apr 261.95
Apr 261.9
Apr 261.51
Apr 262.09
Mar 261.67
Mar 261.55
Mar 261.9
Mar 261.9
Feb 261.63
Feb 261.4
Feb 261.4
Feb 261.36
Jan 261.55
Jan 261.55
Jan 262.06
Jan 262.52
Jan 263.42
Dec 252.33
Dec 251.9
Dec 251.55
Dec 251.55
Nov 251.55
Nov 251.75
Nov 251.75
Nov 252.19
Oct 252.43
Oct 252.34
Oct 252.34
Oct 251.46
Oct 251.46
Sep 251.46
Sep 251.46
Sep 251.46
Sep 251.56
Aug 251.46
Aug 251.46
Aug 251.56
Aug 251.29
Aug 251.88
Jul 251.88
Jul 251.76
Jul 252.05
Jul 252.29
Jun 252.29
Jun 251.88
Jun 252.35
Jun 252.58
May 251.99
May 252.87
May 251.82
May 252.52
May 253.35
Apr 253.35
Apr 253.35
Apr 254.19
Apr 259.02
Mar 257.84
Mar 257.84
Mar 2510.78
Mar 2510.78
Feb 257.84
Feb 2513.72
Feb 2513.72
Feb 2514.11
Jan 2514.11
Jan 2514.5
Jan 2516.46
Jan 2510
Jan 2515.48
Dec 2414.7
Dec 2415.29
Dec 2415.68
Dec 2415.68
Nov 2415.29
Nov 2417.25
Nov 2419.6
Nov 24239.07
Nov 24279.76
Oct 24249.24
Oct 24249.24
EV/EBITDA
2468med 4.96Jun 24Sep 24Nov 24Jan 25Mar 25Jun 25Aug 25
CPMD EV/EBITDA by quarter
PeriodEV/EBITDA
Aug 253.35
Aug 253.47
Jul 253.47
Jul 253.44
Jul 253.51
Jul 253.55
Jun 253.55
Jun 253.47
Jun 253.57
Jun 253.61
May 253.49
May 253.68
May 253.46
Apr 254.55
Mar 254.44
Mar 254.44
Mar 254.7
Mar 254.7
Feb 254.44
Feb 254.96
Feb 254.96
Feb 255
Jan 255
Jan 255.03
Jan 255.2
Jan 254.63
Jan 255.12
Dec 245.05
Dec 245.1
Dec 245.13
Dec 245.13
Nov 245.1
Nov 245.27
Nov 245.48
Nov 246.91
Nov 247.27
Oct 247
Oct 247
Oct 247.02
Oct 246.64
Sep 247.27
Sep 247.05
Sep 246.59
Sep 247.05
Aug 246.93
Aug 247.08
Aug 247.16
Jun 243.2
Jun 243.34
Jun 243.41
May 243.29
May 243.3
May 243.04
Price to Book
020406080med 6.09Jul 19Nov 19Feb 20May 20Sep 20Dec 20Apr 21
CPMD Price to Book by quarter
PeriodPrice to Book
Apr 216.57
Apr 216.8
Mar 216.61
Mar 217.88
Mar 217.34
Mar 218.97
Feb 2111.69
Feb 2113.29
Feb 2116.04
Feb 2110.33
Jan 2111.15
Jan 2110.19
Jan 2111.96
Jan 2111.96
Dec 2013.32
Dec 2012.51
Dec 208.7
Dec 206.66
Dec 209.24
Nov 209.81
Nov 2010.6
Nov 2010.06
Nov 206.16
Oct 205.94
Oct 206.47
Oct 207.04
Oct 206.02
Oct 207.63
Sep 209.24
Sep 209.54
Sep 208.36
Sep 2011.88
Aug 2015.4
Aug 2031.54
Aug 2067.57
Aug 2063.84
Jul 2058.95
Jul 2066.14
Jul 2032.21
Jul 2031.92
Jul 2029.04
Jun 206.82
Jun 207.04
Jun 207.49
Jun 209.14
May 2010.86
May 203.68
May 202.02
May 201.37
May 201.37
Apr 201.37
Apr 201.37
Apr 201.34
Apr 201.14
Mar 202.29
Mar 201.91
Mar 202.96
Mar 203.68
Feb 202.96
Feb 203.58
Feb 203.98
Feb 203.74
Jan 203.77
Jan 203.55
Jan 204.03
Jan 203.85
Jan 203.39
Dec 193.23
Dec 194.44
Dec 194.95
Dec 194.2
Nov 194.3
Nov 194.6
Nov 194.63
Nov 194.82
Nov 194.82
Oct 195.42
Oct 195.89
Oct 195.89
Oct 195.87
Sep 197.02
Sep 196.88
Sep 196.88
Sep 196.88
Aug 196.39
Aug 195.67
Aug 196.75
Aug 193.62
Aug 193.58
Jul 193.49
Jul 192.72
Jul 194.47
Jul 193.26
Jun 192.56
Jun 192.63
Jun 193.28
Jun 192.26
May 192.79
May 192.7
May 193.31
CannaPharmaRX, Inc.
CPMD
Stockpicker

Video analysis: CPMD

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.